Japanese encephalitis virus vaccine nakayama Alternatives Compared
Japanese encephalitis virus vaccine nakayama | Ixiaro (japanese enceph vacc sa14-14-2, inactivated) | Japanese enceph vacc sa14-14-2, inactivated |
|
---|
Japanese encephalitis virus vaccine nakayama | Ixiaro (japanese enceph vacc sa14-14-2, inactivated) | Japanese enceph vacc sa14-14-2, inactivated |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Japanese Encephalitis Virus Prophylaxis. Japanese encephalitis virus vaccine nakayama may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Japanese Encephalitis Virus Prophylaxis. Ixiaro may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Japanese Encephalitis Virus Prophylaxis. Japanese enceph vacc sa14-14-2, inactivated may also be used for purposes not listed in this medication guide. |
||||||||
More about Ixiaro (japanese enceph vacc sa14-14-2, inactivated) | More about Japanese enceph vacc sa14-14-2, inactivated | |||||||||
Ratings & Reviews | ||||||||||
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
View all Japanese encephalitis virus vaccine nakayama side effects |
View all Ixiaro side effects |
View all Japanese enceph vacc sa14-14-2, inactivated side effects |
||||||||
Drug Class | ||||||||||
Generic Availability | ||||||||||
N/A |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Ixiaro prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | ||||||||||
N/A |
|
N/A |
||||||||
Brand Names | ||||||||||
N/A |
N/A |
Ixiaro | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
N/A |
N/A |
N/A |
||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 298 drugs are known to interact with Japanese encephalitis virus vaccine nakayama:
|
A total of 298 drugs are known to interact with Ixiaro:
|
A total of 298 drugs are known to interact with Japanese enceph vacc sa14-14-2, inactivated:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
N/A |
N/A |
N/A |
||||||||
WADA Class View classifications | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient Resources | ||||||||||
N/A |
||||||||||
Professional Resources | ||||||||||
N/A |
||||||||||
Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.